Herein, we demonstrate that PR-B activation by hydroxyprogesterone (OHPg), has an active part in the inhibition of cell migration and invasion, by reducing cytoplasmic CD1 in breast cancer cells. This evidence concerns the gene RB1 and breast cancer.